Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew D Badley

Showing results (21-30 of 156) with videos related to

Pageof 16
Sort By:
Journal of Cell Death|October 11, 2016
Casp8p41: The Protean Mediator of Death in CD4 T-cells that Replicate HIVRahul Sampath, Nathan W Cummins, Andrew D Badley
Oncotarget|April 19, 2021
The long road to TRAIL therapy: a TRAILshort detourAswath P Chandrasekar, Mark Maynes, Andrew D Badley
AIDS (London, England)|July 2, 2005
Acquired T-cell sensitivity to TRAIL mediated killing during HIV infection is regulated by CXCR4-gp120 interactionsJulian J Lum, David J Schnepple, Andrew D Badley
Clinical Microbiology Reviews|November 1, 2019
The Role of the BCL-2 Family of Proteins in HIV-1 Pathogenesis and PersistenceAswath P Chandrasekar, Nathan W Cummins, Andrew D Badley
AIDS Research and Human Retroviruses|October 30, 2019
Mechanisms of Human Immunodeficiency Virus-Associated Lymphocyte Regulated Cell DeathAna C Paim, Andrew D Badley, Nathan W Cummins
Mayo Clinic Proceedings|May 7, 2021
A Blueprint to Control the SARS-CoV-2 PandemicJohn C O'Horo, Amy W Williams, Andrew D Badley
The Open Virology Journal|July 3, 2009
CD4 T Cells Treated with gp120 Acquire a CD45R0+/CD45RA+ PhenotypeSergey A Trushin, Gary D Bren, Andrew D Badley
HIV Clinical Trials|June 20, 2003
Attenuated T-lymphocyte response to HIV therapy in individuals receiving HMG-CoA reductase inhibitorsShanil Narayan, Nanci Hawley, Pierre Giguère, et al.
The Journal of Infectious Diseases|March 16, 2010
How much gp120 is there?Nathan W Cummins, Stacey A Rizza, Andrew D Badley
The Open Virology Journal|September 14, 2010
CXCR4 Tropic HIV-1 gp120 Inhibition of SDF-1α-Induced Chemotaxis Requires Lck and is Associated with Cofilin PhosphorylationSergey A Trushin, Gary D Bren, Andrew D Badley
Pageof 16

Showing results (21-30 of 156) with videos related to

Sort By:
Pageof 16
Journal of Cell Death|October 11, 2016
Casp8p41: The Protean Mediator of Death in CD4 T-cells that Replicate HIVRahul Sampath, Nathan W Cummins, Andrew D Badley
Oncotarget|April 19, 2021
The long road to TRAIL therapy: a TRAILshort detourAswath P Chandrasekar, Mark Maynes, Andrew D Badley
AIDS (London, England)|July 2, 2005
Acquired T-cell sensitivity to TRAIL mediated killing during HIV infection is regulated by CXCR4-gp120 interactionsJulian J Lum, David J Schnepple, Andrew D Badley
Clinical Microbiology Reviews|November 1, 2019
The Role of the BCL-2 Family of Proteins in HIV-1 Pathogenesis and PersistenceAswath P Chandrasekar, Nathan W Cummins, Andrew D Badley
AIDS Research and Human Retroviruses|October 30, 2019
Mechanisms of Human Immunodeficiency Virus-Associated Lymphocyte Regulated Cell DeathAna C Paim, Andrew D Badley, Nathan W Cummins
Mayo Clinic Proceedings|May 7, 2021
A Blueprint to Control the SARS-CoV-2 PandemicJohn C O'Horo, Amy W Williams, Andrew D Badley
The Open Virology Journal|July 3, 2009
CD4 T Cells Treated with gp120 Acquire a CD45R0+/CD45RA+ PhenotypeSergey A Trushin, Gary D Bren, Andrew D Badley
HIV Clinical Trials|June 20, 2003
Attenuated T-lymphocyte response to HIV therapy in individuals receiving HMG-CoA reductase inhibitorsShanil Narayan, Nanci Hawley, Pierre Giguère, et al.
The Journal of Infectious Diseases|March 16, 2010
How much gp120 is there?Nathan W Cummins, Stacey A Rizza, Andrew D Badley
The Open Virology Journal|September 14, 2010
CXCR4 Tropic HIV-1 gp120 Inhibition of SDF-1α-Induced Chemotaxis Requires Lck and is Associated with Cofilin PhosphorylationSergey A Trushin, Gary D Bren, Andrew D Badley
Pageof 16